International

BIO promotes science-based policies and protect market-based incentives to enable the growth of the global biotechnology ecosystem.

Global collaboration is increasingly important as governments around the world seek to develop comprehensive policy frameworks to support biotechnology innovation. Through collaboration and dialogue, we can create a global policy environment that enables the biotechnology sector to meet societal needs, such as treating and curing disease, mitigating climate change and feeding a growing global population.

building the bio-economy
Building the Bioeconomy

Building a strong biotechnology sector is a strategic priority and part of an increasing number of countries’ economic vision. Through a collaboration with the Pugatch Consilium, BIO helps governments understand the best ways to encourage innovation and attract investment. The report “Building the Bioeconomy” evaluates countries’ progress towards building their bioeconomies with a data-driven approach, comparing economies with over 20 policy inputs and biotech outputs showing how regulations affect success or failure in driving industry growth.

Emerging Opportunities in Global Markets

At the annual BIO International Convention, BIO provides a forum to highlight biotech initiatives in global markets, looking at both emerging economies and other global initiatives and trends (trade agreements, IP trends) that affect the industry’s landscape.  The Forum provides an overview of developments in key markets, as well as cross-cutting policy trends. It also examines unique collaborations and cross-border initiatives to further innovation.

BIO-International-global-market
Featured International Events

BIO works with partners around the world to host events aimed at enabling dialogue between governments and industry, as well as creating business development opportunities for entrepreneurs. Learn more about BIO’s international event portfolio.

Press Releases
May 9, 2024
House lawmakers today unveiled a new draft of the BIOSECURE Act. Shortly after, BIO President and CEO, John F. Crowley, made the following statement: "The BIOSECURE bill released in the House today reinforces the national security imperative of the biotechnology industry as a critical strategic…
March 13, 2024
BIO President & CEO John F. Crowley announced today that BIO would take several important steps to reaffirm the organization’s position with regards to national security and the role that the industry plays as a vital strategic asset: “As a combat veteran and former Naval Intelligence Officer…
October 17, 2023
The United States International Trade Commission (USITC) today released its “COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities” report. The report aims to analyze various issues and information gaps concerning COVID-19 diagnostics and therapeutics.  …